T1 characteristics of interstitial pulmonary fibrosis on 3T MRI'a predictor of early interstitial change?

Quantitative Imaging in Medicine and Surgery

Volumn 6, Issue 1, 2016, Pages 42-49

  Mirsadraee, Saeed ^a   Tse, Matthew ^a   Kershaw, Lucy ^a   Semple, Scott ^a   Schembri, Nicola ^a   Chin, Calvin ^a   Murchison, John T ^a   Hirani, Nik ^a   Van Beek, Edwin J R ^a  

^a UNIVERSITY OF EDINBURGH   (United Kingdom)

Author keywords

Diagnosis; Magnetic resonance imaging (MRI); Pulmonary fibrosis (PF); T1 mapping

Indexed keywords

GADOLINIUM;

AGED; ARTICLE; CLINICAL ARTICLE; CONTRAST ENHANCEMENT; CONTROLLED STUDY; FEASIBILITY STUDY; FEMALE; FIBROSING ALVEOLITIS; HIGH RESOLUTION COMPUTER TOMOGRAPHY; HUMAN; MALE; NUCLEAR MAGNETIC RESONANCE IMAGING; PILOT STUDY; PREDICTION; REPRODUCIBILITY;

EID: 84986225093     PISSN: 22234292     EISSN: 22234306     Source Type: Journal    
DOI: 10.3978/j.issn.2223-4292.2016.02.02     Document Type: Article

References (19)

1. King TE Jr, Pardo A, Selman M. Idiopathic pulmonary fibrosis. Lancet 2011;378:1949-61.
2. Nicholson AG, Colby TV, du Bois RM, Hansell DM, Wells AU. The prognostic significance of the histologic pattern of interstitial pneumonia in patients presenting with the clinical entity of cryptogenic fibrosing alveolitis. Am J Respir Crit Care Med 2000;162:2213-7.
3. Souza CA, Möller NL, Flint J, Wright JL, Churg A. Idiopathic pulmonary fibrosis: spectrum of high-resolution CT findings. AJR Am J Roentgenol 2005;185:1531-9.
4. National Institute for Health and Care Excellence: Clinical Guidelines. Diagnosis and Management of Suspected Idiopathic Pulmonary Fibrosis: Idiopathic Pulmonary Fibrosis. London: Royal College of Physicians (UK), 2013.
5. Carneiro AO, Vilela GR, de Araujo DB, Baffa O. MRI Relaxometry: Methods and Applications. Brazil J Phys 2006;36:9-15.
6. Moon JC, Messroghli DR, Kellman P, Piechnik SK, Robson MD, Ugander M, Gatehouse PD, Arai AE, Friedrich MG, Neubauer S, Schulz-Menger J, Schelbert EB; Society for Cardiovascular Magnetic Resonance Imaging; Cardiovascular Magnetic Resonance Working Group of the European Society of Cardiology. Myocardial T1 mapping and extracellular volume quantification: A Society for Cardiovascular Magnetic Resonance (SCMR) and CMR Working Group of the European Society of Cardiology consensus statement. J Cardiovasc Magn Reson 2013;15:92.
7. Gowland PA, Stevenson VL. The Longitudinal Relaxation Time. In: Tofts P, editor. Quantitative MRI of the Brain: Measuring Changes Caused by Disease. Chichester, UK: John Wiley & Sons, Ltd, 2003:111-42.
8. Caillé JM, Lemanceau B, Bonnemain B. Gadolinium as a contrast agent for NMR. AJNR Am J Neuroradiol 1983;4:1041-2.
9. Burt JR, Zimmerman SL, Kamel IR, Halushka M, Bluemke DA. Myocardial T1 mapping: Techniques and potential applications. Radiographics 2014;34:377-95.
10. Sparrow P, Messroghli DR, Reid S, Ridgway JP, Bainbridge G, Sivananthan MU. Myocardial T1 mapping for detection of left ventricular myocardial fibrosis in chronic aortic regurgitation: pilot study. AJR Am J Roentgenol 2006;187:W630-5.
11. Kali A, Choi EY, Sharif B, Kim YJ, Bi X, Spottiswoode B, Cokic I, Yang HJ, Tighiouart M, Conte AH, Li D, Berman DS, Choi BW, Chang HJ, Dharmakumar R. Native T1 Mapping by 3-T CMR Imaging for Characterization of Chronic Myocardial Infarctions. JACC Cardiovasc Imaging 2015;8:1019-30.
12. Lee SP, Lee W, Lee JM, Park EA, Kim HK, Kim YJ, Sohn DW. Assessment of diffuse myocardial fibrosis by using MR imaging in asymptomatic patients with aortic stenosis. Radiology 2015;274:359-69.
13. Bull S, White SK, Piechnik SK, Flett AS, Ferreira VM, Loudon M, Francis JM, Karamitsos TD, Prendergast BD, Robson MD, Neubauer S, Moon JC, Myerson SG. Human non-contrast T1 values and correlation with histology in diffuse fibrosis. Heart 2013;99:932-7.
14. Messroghli DR, Radjenovic A, Kozerke S, Higgins DM, Sivananthan MU, Ridgway JP. Modified Look-Locker inversion recovery (MOLLI) for high-resolution T1 mapping of the heart. Magn Reson Med 2004;52:141-6.
15. Akaike H. A New Look at the Statistical Model Identification. IEEE Trans Autom Control 1974;19:716-23.
16. Bland JM, Altman DG. Statistical methods for assessing agreement between two methods of clinical measurement. Lancet 1986;1:307-10.
17. Falque C, Kober F, Bernard M, Jacquier A. Intersite reproducibility of myocardial assessment of T1 and partition coefficient on phantom and one volunteer at 1.5T and 3.0T. J Cardiovasc Magn Reson 2014;16:79.
18. Moon JC, Sheppard M, Reed E, Lee P, Elliott PM, Pennell DJ. The histological basis of late gadolinium enhancement cardiovascular magnetic resonance in a patient with Anderson-Fabry disease. J Cardiovasc Magn Reson 2006;8:479-82.
19. Stadler A, Jakob PM, Griswold M, Barth M, Bankier AA. T1 mapping of the entire lung parenchyma: Influence of the respiratory phase in healthy individuals. J Magn Reson Imaging 2005;21:759-64.